Search
for
Sort by
Research 211–240 of 1000+
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Pharmacology of anabolic steroids
- Intracrine androgen biosynthesis, metabolism and action revisited
- Androgen receptor–mediated inhibition of cutaneous wound healing
- Diagnosis of hyperandrogenism: clinical criteria
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Effect of 5α-Dihydrotestosterone and Testosterone on Apoptosis in Human Dermal Papilla Cells
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Redefining hormone resistance in prostate cancer
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Regional Variation in Androgen Receptor Expression and Biomechanical Properties May Contribute to Cryptorchidism Susceptibility in the LE/orl Rat
- Muscle pain in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency resolved with testosterone therapy. A case report with 10 years of follow-up
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Androgens’ Effects across the Lifespan in Men and Animal Models
- Polycystic Ovary Syndrome in Adolescents
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Is dehydroepiandrosterone a hormone?
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Frontal fibrosing alopecia in postmenopausal women
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Gender differences in skin: A review of the literature
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer